Market Place
Sourcing Support
Torrent Pharma`s Generic Teriflunomide Receives Approval in the U.S.
04 Apr 2024 //
FDA
Merck KGaA suffers major blow as MS drug fails in late-stage trials
06 Dec 2023 //
REUTERS
Tiefenbacher Pharmaceuticals Launch Of Generic Teriflunomide
27 Sep 2023 //
PRESS RELEASE
Glenmark reports Rs 403 crore loss in Q4FY23
19 May 2023 //
ECONOMIC TIMES
Alembic intros generic Aubagio
22 Mar 2023 //
DRUGSTORENEWS
Stem cell transplants may slow disability progression in MS
22 Dec 2022 //
EUROPEANPHARMACEUTICALREVIEW
Accord`s Teriflunomide Receives Approval in Europe
14 Nov 2022 //
EMA
Tiefenbacher Launches 1st Generic Version Of MS Medicine Teriflunomide In Canada
02 Jun 2022 //
PRESS RELEASE
Apotex Launches Affordable Generic Option to Treat Relapsing Remitting Multiple Sclerosis
17 May 2022 //
PRESS RELEASE
New MAVENCLAD Data at ACTRIMS Forum 2022 Show Favourable Efficacy Outcomes
24 Feb 2022 //
BUSINESSWIRE
Subgroup Analysis: Benefits of PONVORYTM over teriflunomide in Phase 3 Study
13 Oct 2021 //
BUSINESSWIRE
Teriflunomide – API and Licensing Agreements for Tablets available
06 Oct 2021 //
PRESS RELEASE
Breckenridge Announces Approval of its ANDA for Teriflunomide Tablets (generic for Aubagio®)
29 Sep 2021 //
PRNEWSWIRE
Breckenridge`s Generic Teriflunomide Receives Approval In US
24 Sep 2021 //
FDA
EC approves Sanofi’s Aubagio for paediatric MS patients
21 Jun 2021 //
PHARMA TIMES
Patients Data for Investigational Ublituximab vs Teriflunomide: Presented at EAN
21 Jun 2021 //
FIRSTWORDPHARMA
TG Therapeutics to present Data for Ublituximab in MS at 7th Congress of the EAN
18 Jun 2021 //
GLOBENEWSWIRE
European Commission approves Aubagio as the first oral MS therapy
18 Jun 2021 //
GLOBENEWSWIRE
FDA turns down Sanofi filing seeking to extend MS drug Aubagio to children
14 Jun 2021 //
FIRSTWORLDPHARMA
TG Therapeutics’ ublituximab tops Sanofi’s Aubagio in MS trial
19 Apr 2021 //
PHARMATIMES
Novartis sues FDA, claiming Sanofi`s Aubagio isn`t really new
12 Mar 2021 //
FIERCE PHARMA
Impax Lab’s Generic Teriflunomide Receives Tentative Approval In US
25 Jun 2020 //
FDA
Impax Lab’s Generic Teriflunomide Receives Approval In US
25 Jun 2020 //
FDA
Novartis` leukemia drug tops Sanofi`s Aubagio in MS study
28 May 2020 //
FIERCE PHARMA
J&J aims for US approval of MS drug ponesimod
20 Mar 2020 //
PMLIVE
J&J pitches its S1P1 MS drug into the regulatory ring as the competition heats
20 Mar 2020 //
ENDPTS
Novartis` reinvented leukemia drug bests Sanofi`s Aubagio in MS
14 Sep 2019 //
FIERCE PHARMA
Novartis MS drug cuts relapse rate by half compared to Sanofi medicine
13 Sep 2019 //
REUTERS
J&J`s head-to-head PhIII data promise drug launch into crowded MS market
13 Sep 2019 //
ENDPOINTSNEWS
J&J multiple sclerosis hopeful tops Aubagio at reducing relapse, fatigue
12 Sep 2019 //
FIERCE BIOTECH
Novartis reports positive Phase III data for multiple sclerosis drug
03 Sep 2019 //
CLINICALTRIALSARENA
Novartis` repurposed cancer drug Arzerra outpaces Sanofi`s Aubagio in MS trial
31 Aug 2019 //
FIERCE PHARMA
MS drug boosts effectiveness of cancer therapy in treating glioblastoma
09 Aug 2019 //
PHARMAFILE
Janssen’s ponesimod holds up against Aubagio in late-stage trial
29 Jul 2019 //
PHARMA TIMES
Alembic Pharms Generic Teriflunomide Receives Approval in US
26 Apr 2019 //
FDA
Sandoz`s Generic Teriflunomide Receives Approval in US
03 Jan 2019 //
FDA
Zydus Pharms`s Generic Teriflunomide Receives Approval in US
30 Nov 2018 //
FDA
Apotex`s Generic Teriflunomide Receives Approval in US
15 Nov 2018 //
FDA
Glenmark gets USFDA nod for multiple sclerosis medication
15 Nov 2018 //
DNA INDIA
Amneal Pharms` Generic Teriflunomide Receives Approval in US
01 Nov 2018 //
FDA
Can Sanofi`s new long-term Lemtrada data amp up MS sales?
12 Oct 2018 //
FIERCE PHARMA
Sanofi presents new data on Aubagio® (teriflunomide)
10 Oct 2018 //
BUSINESSWIRE
Amneal Pharms` Generic Teriflunomide Receives Approval in US
02 Oct 2018 //
FDA
Teva Pharms USA`s Generic Teriflunomide Receives Approval in US
08 Sep 2018 //
FDA
Alvogen Pine Brook`s Generic Teriflunomide Receives Tentative Approval in US
22 Aug 2018 //
FDA
Watson Labs Teva`s Generic Teriflunomide Receives Approval In US
28 Jul 2018 //
FDA
Sanofi’s internal memo after a subpoena illustrates concerns over MS drug Mkg
30 May 2018 //
STATNEWS
Lawmakers dig into `skyrocketing` MS costs with probe into 7 drugmakers
17 Aug 2017 //
FIERCE PHARMA
New Data Suggest Positive Effects of Sanofi Genzyme’s Aubagio
25 Apr 2017 //
BUSINESSWIRE
Patient requests buoy oral meds from Biogen, Novartis in crowded MS market
26 Jan 2017 //
FIERCE PHARMA
Impax Confirms Patent Challenge Relating to Generic Aubagio Tablets
07 Jan 2017 //
PR NEWSWIRE
Merck KGaA launches story-sharing template to help MS patients chronicle journey
21 Dec 2016 //
FIERCE PHARMA
Bayer blazes new trails for pharma with Betaseron Facebook ad
31 Oct 2016 //
FIERCE PHARMA
Tecfidera, Gilenya and Aubagio`s 3-way battle for MS share is about to heat up
31 Oct 2016 //
FIERCE PHARMA
Sanofi’s weak Q1 cancer drug sales spur Medivation buyout desire
29 Apr 2016 //
FIERCE PHARMA
Study By Spherix Global Insight Indicate Therapy Switching Rates For MS Patients
15 Apr 2016 //
PR NEWSWIRE
EU revokes one of the patents on Biogen blockbuster Tecfidera
12 Mar 2016 //
FIERCE PHARMA
Sanofi`s outlook less than sunny as key diabetes franchise continues to sag
09 Feb 2016 //
FIERCE PHARMA
Another setback for Teva`s laquinimod in MS
05 Jan 2016 //
PM LIVE
Gilead, Sanofi singled out as worst offenders in failing to disclose trial data
12 Nov 2015 //
FIERCE BIOTECH
